Alzheimer's Disease Clinical Trials in Philadelphia

Showing 61-80 of 127 trials

Engaging Caregivers in Dementia Care

NCT02552563

This pilot study seeks to examine the extent to which, relative to usual care, a dementia care management program for veterans and their caregivers (CGs)improves patient (e.g., behavioral symptoms, delayed nursing home placement) and caregiver (e.g., CG mastery, burden, affect) outcomes.

Dementia

Corporal Michael J. Crescenz VA Medical Center75 participantsStarted Feb 2011

Philadelphia, Pennsylvania, United States

COMPLETEDPHASE3< 1 mile

Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease

NCT02547818

This is a global Phase III, randomized, double-blinded, placebo-controlled study for subjects with evidence of early AD. The protocol is designed to determine whether ALZT-OP1 combination treatment (ALZT-OP1a + ALZT-OP1b) will slow down, arrests, or reverse cognitive and functional decline, in subjects with evidence of early stage Alzheimer's disease (AD).

Alzheimer's Disease

AZTherapies, Inc.620 participantsStarted Sep 2015

Gilbert, Arizona, United States • Phoenix, Arizona, United States • Scottsdale, Arizona, United States +118 more locations

Engaging Caregivers in Dementia Care

Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease

Alzheimer's Disease Trials in Other Cities

Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL)

Study Evaluating the Safety, Tolerability, and Efficacy of Lecozotan SR in Outpatients With Alzheimer's Disease

To Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients.

A Study of Gantenerumab in Participants With Mild Alzheimer Disease

ITI-007 for the Treatment of Agitation in Patients With Dementia, Including Alzheimer's Disease

A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease

2-Year Extension Study of Azeliragon in Subjects With Alzheimer's Disease (STEADFAST Extension)

Phase 2 Study of BIIB092 in Participants With Early Alzheimer's Disease

A Study to Evaluate Efficacy and Safety of BAC in Patient With Alzheimer's Disease or Vascular Dementia

Study of Azeliragon in Patients With Mild Alzheimer's Disease and Impaired Glucose Tolerance

A Study of Brain Aging in Vietnam War Veterans

A Multicenter Placebo-Controlled Double-Blind Trial to Evaluate Azidothymidine (AZT) Treatment of the AIDS Dementia Complex and Central Nervous System (CNS) Human Immunodeficiency Virus (HIV) Infection

A Phase I Study for Safety and Tolerability of AL002.

Randomized Evaluation of Default Access to Palliative Services

18F-AV-1451 Autopsy Study

Cholinesterase Inhibitor Discontinuation

Renew NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild Dementia of the Alzheimer's Type

Neuro RX Gamma - Pivotal Phase

Other Conditions in Philadelphia